TREATMENT OF INTERMEDIATE-OR HIGH-RISK PROSTATE CANCER BY DOSE ESCALATION WITH HIGH-DOSE 3D-CONFORMAL RADIOTHERAPY (HD-3D-CRT) OR LOW-DOSE 3D-CONFORMAL RADIOTHERAPY PLUS HDR BRACHYTHERAPY (LD-3D-CRT+HDR-B) : EARLY RESULTS OF A PROSPECTIVE COMPARATIVE TRIAL

被引：0

作者：

Guix, B. ^{[1
]}

Bartrina, J. M. ^{[1
]}

Tello, J. I. ^{[1
]}

Sole, J. ^{[1
]}

Quinzanos, L. ^{[1
]}

Lacorte, T. ^{[1
]}

Leon, F. ^{[1
]}

Fernandez, J. ^{[1
]}

Henriquez, I. ^{[1
]}

Guix, I. ^{[1
]}

Galdon, G. ^{[1
]}

Espino, M. ^{[1
]}

机构：

[1] IMOR Fdn, Med Inst Radiotherapy & Oncol, Radiat Oncol, Prostate Canc Unit, Barcelona, Spain

来源：

RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1240

引用

页码：S418 / S418

页数：1

共 50 条

[31] Tolerance and efficacy of high-dose 3D-conformal radiation therapy (CRT) in cirrhotic patients with small hepatocellular carcinomas (HCC) not suitable for curative therapies [J].

Mornex, F ;

Merle, P ;

Beziat, C ;

Wautot, V ;

Kubas, A ;

Khodri, M ;

Bottigioli, D ;

Trepo, C .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02) :S15-S15

[32] 3D-CONFORMAL EXTERNAL RADIOTHERAPY (3D-CRT) GIVEN CONCURRENTLY WITH DOCETAXEL AND CISPLATINUM AS RADICAL TREATMENT FOR PATIENTS WITH INOPERABLE HIGH RISK ADENOCARCINOMA OF THE PROSTATE. A PHASE I/II STUDY. [J].

Sakarelis, P. ;

Varveris, A. ;

Varveris, C. .

RADIOTHERAPY AND ONCOLOGY, 2010, 96 :S254-S254

[33] Comparison of dose calculation algorithms model: Convolution, superposition, and fast superposition in 3-D Conformal Radiotherapy (3D-CRT) treatment plan [J].

Murat, H. ;

Karim, M. K. A. ;

Harun, H. H. ;

Kayun, Z. .

18TH ASIA-OCEANIA CONGRESS OF MEDICAL PHYSICS (AOCMP) & 16TH SOUTH-EAST ASIA CONGRESS OF MEDICAL PHYSICS (SEACOMP), 2019, 1248

[34] Tolerance and efficacy of high dose 3D-conformal radiotherapy for small size hepatocellular carcinoma not suitable for curative therapies in cirrhotic patients [J].

Merle, P ;

Beziat, C ;

Wautot, V ;

Bottigioli, D ;

Kubas, A ;

Trepo, C ;

Mornex, F .

JOURNAL OF HEPATOLOGY, 2005, 42 :98-99

[35] Dose-volume Comparison of 3D-conformal Radiation Therapy (3D-CRT) and Intensity Modulated Radiation Therapy (IMRT) for Salvage or Adjuvant Treatment of the Prostatic Bed [J].

Shapiro, R. ;

Zook, J. ;

Bartlett, G. ;

Hoene, T. ;

Das, I. ;

Ko, S. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03) :S755-S755

[36] Risk of elective nodal failure in 3D-conformal radiotherapy (CRT) for NSCLC patients: Does it depend on dose received by particular lymph node station or is disease-related? [J].

Kepka, L. ;

Garmol, D. ;

Bujko, K. .

RADIOTHERAPY AND ONCOLOGY, 2006, 81 :S395-S396

[37] High-dose 3D-Conformal Radiation Therapy (CRT): a new curative treatment for patients with small hepatocellular carcinomas (HCC). Mature results of a French phase II trial (RTF1) [J].

Mornex, F. ;

Wautot, V. ;

Kubas, A. ;

Serres, A. ;

Maillard, E. ;

Trepo, C. ;

Merle, P. .

EJC SUPPLEMENTS, 2007, 5 (04) :271-271

[38] High-dose 3D-conformal radiation therapy (CRT): A new curative treatment for patients with small hepatocellular carcinomas (HCC). Mature results of a french phase II trial (RTF1) [J].

Mornex, F. ;

Wautot, V ;

Kubas, A. ;

Maillard, E. ;

Trepo, C. ;

Merle, P. .

ANNALS OF ONCOLOGY, 2007, 18 :VII102-VII102

[39] Patient positioning variations to reduce dose to normal tissues during 3D conformal radiotherapy for high-risk prostate cancer [J].

Czigner, K. ;

Agoston, P. ;

Forgacs, G. ;

Kasler, M. .

STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (09) :816-822

[40] Risk-adapted high-dose 3D-radiotherapy combined with hormonal treatment for prostate cancer [J].

Iturre, E. Villafranca ;

Rojano, P. Romero ;

de la Vega, F. Arias ;

Dominguez, M. A. Dominguez ;

Lopez, E. Martinez ;

Burgaleta, A. Manterola ;

Felipe, G. Asin ;

Oses, M. Rico ;

Pellejero, S. .

EJC SUPPLEMENTS, 2007, 5 (04) :297-297

← 1 2 3 4 5 →